Zonisamide

From WikiMD's WELLNESSPEDIA

Overview of the use of Zonisamide in medical treatment

Zonisamide

Zonisamide




Chemical nomenclature
IUPAC name 1,2-benzisoxazole-3-methanesulfonamide


























Zonisamide is a medication primarily used as an adjunctive therapy in the treatment of epilepsy. It is classified as a sulfonamide and is known for its anticonvulsant properties. Zonisamide is effective in managing partial seizures and is sometimes used off-label for other neurological conditions.

Pharmacology[edit]

Zonisamide works by stabilizing neuronal membranes and suppressing neuronal hypersynchronization through the inhibition of voltage-sensitive sodium and calcium channels. It also modulates the release of neurotransmitters, which contributes to its anticonvulsant effects.

Indications[edit]

Zonisamide is indicated for the treatment of partial seizures in adults with epilepsy. It is often used in combination with other antiepileptic drugs (AEDs) when monotherapy is insufficient.

Dosage and Administration[edit]

The dosage of zonisamide is typically individualized based on the patient's response and tolerance. It is usually started at a low dose and gradually increased. The medication is available in capsule form and is taken orally.

Side Effects[edit]

Common side effects of zonisamide include dizziness, drowsiness, headache, nausea, and loss of appetite. Serious side effects can include metabolic acidosis, kidney stones, and severe skin reactions. Patients should be monitored for signs of depression or suicidal thoughts.

Contraindications[edit]

Zonisamide is contraindicated in patients with a known hypersensitivity to sulfonamides. Caution is advised in patients with renal impairment or a history of kidney stones.

Mechanism of Action[edit]

Zonisamide's mechanism of action involves the blockade of sodium and calcium channels, which reduces the repetitive firing of neurons. It also has a weak inhibitory effect on carbonic anhydrase, which may contribute to its efficacy in seizure control.

Research and Development[edit]

Ongoing research is exploring the potential use of zonisamide in other neurological disorders, such as Parkinson's disease and migraine prophylaxis. Its neuroprotective properties are also being investigated.

Also see[edit]

References[edit]

  • Zonisamide
    Zonisamide
  • Zonisamide
    Zonisamide

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Zonisamide&oldid=6336542"